Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$1,061,625
-9.92%
Shares
Shares Volume: 18,750 Shares
Average Share Price: $56.62
INSIDER
Rolph Timothy
Chief Scientific Officer (Officer)
reported on Feb 7 2025
traded on Feb 5 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 170,237 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $523,878.98 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 53 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $717,898.1 |
| COMPANY PREVIOUS TRADES |